Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines

Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines

On-Demand 0.5-hour Accredited Podcast

Faculty

James Lewis, PharmD, FIDSA
ID Clinical Pharmacy Supervisor
Oregon Health & Sciences University
Portland, Oregon
 
Program Description
Multiple vaccines to combat COVID-19 have been approved or are under investigation in clinical trials. When discussing COVID-19 vaccination with patients, pharmacists must balance providing factual information with patient perceptions of the vaccine. This podcast will focus on recent safety updates regarding risk of thrombosis with thrombocytopenia syndrome (TTS) observed with viral-vector vaccines. This exploration into the nuances of the available viral-vector vaccine will present potential increased convenience of the single-dose regimen with reported safety concerns of TTS alongside updated guidance and recommendations.

Target audience: Pharmacists
Type of activity: Application
Release date: June 29, 2021
Expiration date: June 29, 2022
Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Articulate the benefits of viral-vector vaccines compared with the risk of thrombosis with thrombocytopenia syndrome (TTS)
• Elaborate on current viral-vector TTS adverse effect incidence data and risk among patients who have received or will receive a viral-vector vaccine

 Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

James Lewis, PharmD, FIDSA, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms